Your browser doesn't support javascript.
loading
Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trial.
Pavasini, Rita; Campo, Gianluca; Serenelli, Matteo; Tonet, Elisabetta; Guiducci, Vincenzo; Escaned, Javier; Moreno, Raul; Casella, Gianni; Cavazza, Caterina; Varbella, Ferdinando; Sacchetta, Giorgio; Arena, Marco; Santos, Ignacio Amat; Ibañes, Enrique Gutiérrez; Scarsini, Roberto; D'Amico, Gianpiero; Ruiz-Poveda, Fernando Lozano; Díez Gil, José Luis; Pignatelli, Gianluca; Iannopollo, Gianmarco; Colaiori, Iginio; Santos, Ramon Calvino; Marrone, Andrea; Fileti, Luca; Rigattieri, Stefano; Barbato, Emanuele; Ocaranza-Sanchez, Raymundo; Biscaglia, Simone.
Afiliação
  • Pavasini R; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.
  • Campo G; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.
  • Serenelli M; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.
  • Tonet E; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.
  • Guiducci V; Cardiology Unit, Azienda USL-IRCCS Reggio Emilia, S. Maria Nuova Hospital, Viale Risorgimento 80, Reggio Emilia 42123, Italy.
  • Escaned J; Cardiovascular Department, Hospital Clínico San Carlos IDISCC, Complutense University of Madrid, Calle del Prof Martin Lagos s/n, Madrid 28040, Spain.
  • Moreno R; Interventional Cardiology, University Hospital La Paz, Paseo La Castellana, 261, 28046, Madrid, Spain.
  • Casella G; Cardiology Unit, Ospedale Maggiore, Largo Nigrisoli 2, Bologna 40133, Italy.
  • Cavazza C; Cardiovascular Department, Infermi Hospital, Viale Luigi Settembrini 2, Rimini 47923, Italy.
  • Varbella F; Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano, and Rivoli Infermi Hospital ASLTO3, Rivoli (TO) 10098, Italy.
  • Sacchetta G; Cardiology Unit, Umberto I Hospital, ASP Siracusa, Via Giuseppe Testaferrata, 1, 96100 Siracusa, Italy.
  • Arena M; S.C. Cardiologia, Ospedale Sant'Andrea, ASL5 Liguria, La Spezia 19124, Italy.
  • Santos IA; Department of Cardiology, Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Hospital Clínico Universitario, Av. Ramón y Cajal, 3, 47003 Valladolid, Spain.
  • Ibañes EG; Department of Cardiology, Centro de Investigation Biomedica end Red en Enfermedades Cardiovasculares, H. Universitario y Politécnico La Fe, Valencia 46026, Spain.
  • Scarsini R; Cardiovascular Department, Azienda Ospedaliero Universitaria Integrata di Verona, Piazzale Aristide Stefani, 1 - 37126 Verona, Italy.
  • D'Amico G; Interventional Cardiology, Department of Cardio-Thoracic and Vascular Sciences, Ospedale dell'Angelo, Via Paccagnella, 12, 35128 Mestre (Venice), Italy.
  • Ruiz-Poveda FL; Cardiovascular Department, Hospital General Universitario de Ciudad Real, 13001, Ciudad Real, Spain.
  • Díez Gil JL; Cardiology Unit, Hospital San Giovanni di Dio, Azienda Sanitaria Provinciale Agrigento, Agrigento 92100, Italy.
  • Pignatelli G; Cardiology Unit, Azienda USL-IRCCS Reggio Emilia, S. Maria Nuova Hospital, Viale Risorgimento 80, Reggio Emilia 42123, Italy.
  • Iannopollo G; Cardiology Unit, Ospedale Maggiore, Largo Nigrisoli 2, Bologna 40133, Italy.
  • Colaiori I; Cardiology Unit, Ospedale Santa Maria Goretti, Via Lucia Scaravelli, Latina 04100, Italy.
  • Santos RC; Department of Interventional Cardiology, Complexo Hospitalario Universitario A Coruña (CHUAC), As Xubias, 84, 15006 A Coruña, Spain.
  • Marrone A; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.
  • Fileti L; Cardiology Department, S. Maria delle Croci Hospital, Viale Randi 5, Ravenna 48121, Italy.
  • Rigattieri S; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa, 1035/1039 00189 Roma, Italy.
  • Barbato E; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa, 1035/1039 00189 Roma, Italy.
  • Ocaranza-Sanchez R; Servicio de Cardiología, Hospital Universitario Lucus Augusti, 27001 Lugo, Spain.
  • Biscaglia S; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.
Eur J Prev Cardiol ; 2024 Mar 07.
Article em En | MEDLINE | ID: mdl-38452238
ABSTRACT

AIMS:

The present analysis from the Functional Assessment in Elderly Myocardial Infarction Patients with Multivessel Disease (FIRE) trial aims to explore the significance of pre-admission physical activity and assess whether the benefits of physiology-guided complete revascularization apply consistently to sedentary and active older patients. METHODS AND

RESULTS:

Patients aged 75 years or more with myocardial infarction (MI) and multivessel disease were randomized to receive physiology-guided complete revascularization or culprit-only strategy. The primary outcome was a composite of death, MI, stroke, or any revascularization within a year. Secondary endpoints included the composite of cardiovascular death or MI, as well as single components of the primary endpoint. Pre-admission physical activity was categorized into three groups (i) absent (sedentary), (ii) light, and (iii) vigorous. Among 1445 patients, 692 (48%) were sedentary, whereas 560 (39%) and 193 (13%) performed light and vigorous physical activity, respectively. Patients engaging in light or vigorous pre-admission physical activity exhibited a reduced risk of the primary outcome compared with sedentary individuals [light hazard ratio (HR) 0.70, 95% confidence interval (CI) 0.55-0.91 and vigorous HR 0.14, 95% CI 0.07-0.91, respectively]. These trends were also observed for death, cardiovascular death, or MI. When comparing physiology-guided complete revascularization vs. culprit-only strategy, no significant interaction was observed for primary and secondary endpoints when stratified by sedentary or active status.

CONCLUSION:

In older patients with MI, pre-admission physical activity emerges as a robust and independent prognostic determinant. Physiology-guided complete revascularization stands out an effective strategy in reducing ischaemic adverse events, irrespective of pre-admission physical activity status. CLINICAL TRIAL REGISTRATION ClinicalTrials.gov NCT03772743.
The Functional Assessment in Elderly Myocardial Infarction Patients with Multivessel Disease (FIRE) trial has shown that physiology-guided complete revascularization reduces ischaemic adverse events in older patients with myocardial infarction (MI) and multivessel disease. Older patients who engage in light or vigorous physical activity before hospitalization for MI have a reduced risk of the primary composite outcome of death, MI, stroke, or ischaemia-driven revascularization. These benefits extend to all secondary cardiovascular outcomes as well. In the present subanalysis of the FIRE trial, we find that the positive prognosis associated with physiology-guided complete revascularization holds true even for patients with a sedentary lifestyle. This means that this type of revascularization can effectively reduce ischaemic adverse events in older patients with MI and multivessel disease, regardless of their physical activity levels.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Eur J Prev Cardiol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Eur J Prev Cardiol Ano de publicação: 2024 Tipo de documento: Article